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Abstract
Background: There is a paucity of data regarding the microbial constituents of tobacco products and their
impacts on public health. Moreover, there has been no comparative characterization performed on the
bacterial microbiota associated with the addition of menthol, an additive that has been used by tobacco
manufacturers for nearly a century. To address this knowledge gap, we conducted bacterial community
profiling on tobacco from user- and custom-mentholated/non-mentholated cigarette pairs, as well as a
commercially-mentholated product. Total genomic DNA was extracted using a multi-step enzymatic and
mechanical lysis protocol followed by PCR amplification of the V3-V4 hypervariable regions of the 16S
rRNA gene from five cigarette products (18 cigarettes per product for a total of 90 samples): Camel Crush,
user-mentholated Camel Crush, Camel Kings, custom-mentholated Camel Kings, and Newport Menthols.
Sequencing was performed on the Illumina MiSeq platform and sequences were processed using the
Quantitative Insights Into Microbial Ecology (QIIME) software package.
Results: In all products, Pseudomonas was the most abundant genera and included Pseudomonas
oryzihabitans and Pseudomonas putida, regardless of mentholation status. However, further comparative
analysis of the five products revealed significant differences in the bacterial compositions across products.
Bacterial community richness was higher among non-mentholated products compared to those that were
mentholated, particularly those that were custom-mentholated. In addition, mentholation appeared to be
correlated with a reduction in potential human bacterial pathogens and an increase in bacterial species
resistant to harsh environmental conditions.
Conclusions: Taken together, these data provide preliminary evidence that the mentholation of commercially
available cigarettes can impact the bacterial community of these products.
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Background
In 2014, an estimated 264 billion cigarettes were sold in
the USA, about one-quarter of which were mentholated
products [1, 2]. Menthol, a cyclic terpene alcohol, is
known to activate cold receptors and provide a “cooling”
sensation [3, 4]. In the 1920s, cigarette companies began
using this additive to reduce the harshness of cigarette
products and to appeal to a wider spectrum of con-
sumers [5, 6]. Although non-menthol cigarettes do con-
tain low levels of menthol, levels in cigarette products
labeled as mentholated are 50–5000 times higher [7].
For commercially produced menthol cigarettes, menthol,
which is usually plant-derived or produced synthetically,
is added directly to the tobacco or to other parts of the
cigarette (e.g., filter, filter paper) [8]. In addition, several
brands of cigarettes (e.g., Camel Crush) have capsules
embedded in the filter, which can be “crushed” by the
user to release a menthol-containing solution. Today,
young adults, minority groups, adult women, and mem-
bers of low-income households are the primary con-
sumers of menthol cigarettes [2, 9, 10].
Previous studies have provided evidence that menthol
smokers are characterized by decreased nicotine metab-
olism, enhanced systemic nicotine exposure [11], in-
creased serum cotinine levels [12], and increased levels
of carboxyhemoglobin [12, 13]. The presence of menthol
in some cigarette products has also been shown to in-
crease levels of volatile organic compounds in main-
stream smoke [14] and inhibit the detoxification of
carcinogens in liver microsome studies [15]. Although
results are mixed [16, 17], it appears that menthol ciga-
rettes may be more addictive and may convey a greater
risk of cancer and other tobacco-related diseases com-
pared to non-mentholated cigarettes [18, 19]. However,
there are relatively few studies that have evaluated other
physiological and toxicological health effects associated
with exposure to menthol cigarettes, including the im-
pact of the bacteria associated with these products on
smokers’ oral health.
The antibacterial nature of menthol has been shown
to inhibit human and plant pathogenic microorganisms;
however, its reaction with the bacterial constituents of
the cigarette microenvironment has yet to be explored
[20]. The history of microorganisms in tobacco has been
documented by several groups [21], with researchers as
early as the late 1890s beginning to characterize the
microbiology of tobacco before and during fermentation.
Fast-forwarding to the 1950s and 1960s, major tobacco
companies and researchers began to produce reports
describing total numbers of cultivable bacteria in
tobacco products [21–24]. More recently, several groups
have used traditional, culture-dependent methods to
identify and characterize specific bacterial and fungal
species present in tobacco products including
Actinomycetes spp. [25], Pantoea spp. [26], Kurthia spp.
[27], Bacillus spp. [27], and Mycobacterium avium (an
important respiratory pathogen) [28].
One study, in particular, recovered viable M. avium
from cigarette tobacco, tobacco paper and the cigarette
filters before cigarettes were smoked and subsequently
recovered viable M. avium from the cigarette filters after
the cigarettes were smoked [28]. These data provide evi-
dence that M. avium can survive exposures to high tem-
peratures and gases generated during the cigarette
combustion process and potentially be inhaled in main-
stream smoke [28]. Other studies have shown that the
mainstream smoke of combustible tobacco products also
contains other microbial constituents, including lipo-
polysaccharides, peptidoglycan fragments and fungal
components [26]. The same study also showed that ciga-
rettes kept at 94% relative humidity for over 8 days were
characterized by additional bacterial and fungal growth
within the cigarette tobacco, further demonstrating that
microorganisms present in the tobacco are viable and
metabolically active [26]. Moreover, in a study by Pauly
et al. [24], bacteria growing on single tobacco flakes
from multiple cigarette brands were characterized, and
the authors hypothesized that these tobacco-associated
microorganisms could represent a health risk to the
smoker as they are carried to the lungs on the surface of
tobacco particulate matter generated during smoking.
The impact of these microbial exposures on tobacco
users’ health is still unclear, as very few epidemiologic
studies have focused on the public health impacts associ-
ated with the microbiological components of tobacco
products. However, bacteria in cigarettes have been pre-
viously associated with acute eosinophilic pneumonitis
in military personnel deployed in operation Iraqi Free-
dom, emphasizing the critical role that these microor-
ganisms might play in acute and chronic conditions
among tobacco users [27].
Culture-based methods that are used to assess the
microbiology of cigarettes, as well as the impacts of
menthol on bacterial populations, are limited due to the
small percentage of bacterial species that can be cul-
tured in the laboratory. Previous work by our group
aimed to address this knowledge gap by applying a 16S
rRNA gene-based taxonomic microarray approach to
evaluate total bacterial diversity of commercially avail-
able cigarettes [29]. In all tested products, 15 different
classes of bacteria and a broad array of potentially
pathogenic microorganisms were identified, including
Acinetobacter spp., Bacillus spp., Clostridium spp., Kleb-
siella spp., Pseudomonas aeruginosa spp., and Serratia
spp. [29]. This initial study also provided some prelimin-
ary evidence that the bacterial microbiota of menthol vs.
non-menthol cigarettes may vary. However, due to the
relatively small number of bacterial taxa represented on
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the microarray used in the previous study, our view of
the bacterial diversity within the tested products was
limited.
Therefore, in this study, we applied high-throughput
next generation sequencing—which provides a much
broader view of total bacterial diversity—to characterize
five cigarette products: Camel Crush, user-mentholated
Camel Crush, Camel Kings, custom-mentholated Camel
Kings, and Newport Menthols. In addition to comparing
mentholated and non-mentholated cigarette pairs we
aimed to identify potential bacterial pathogens that users
may be exposed to when they smoke these products,
and expand our understanding of the scope of bacterial




In the Spring of 2014, menthol and non-menthol ciga-
rettes were either purchased from selected tobacco
stores in College Park, Maryland or provided by our
collaborators at The Battelle Public Health Center for
Tobacco Research (Columbus, OH) (Table 1). The
following products were purchased from selected to-
bacco stores in College Park, MD: (1) Camel Crush,
regular, fresh (CC) (Camel Crush; R.J. Reynolds Tobacco
Co., Winston-Salem, NC, USA), where the capsule
within the filter was subsequently not crushed during
the study; (2) Camel Crush, regular, fresh (CCM), where
the capsule was subsequently crushed during the study
to release a menthol-containing solution into the
cigarette filter (user mentholated) (CCM); and (3) a
commercially mentholated brand, Newport Menthol Box
(NMB) (Lorillard Tobacco Co., Greensboro, NC, USA).
The following products were provide by Battelle: 4)
Camel full flavor, hard pack, king (CK) (Camel Kings;
R.J. Reynolds Tobacco Co., Winston-Salem, NC, USA);
and 5) Camel Kings that were custom-mentholated by
Battelle (CKM) using a vapor deposition technique de-
scribed in detail in MacGregor et al. [30]. The custom-
mentholated Camel Kings were prepared concurrently in
three separate chambers [30]. The Camel Kings that
were not mentholated went through the same motions
and preparations and were handled in the same exact
way as those that were mentholated. The only difference
was that the non-mentholated Camel Kings were not
exposed to the mentholation chamber. All custom-
mentholated and non-mentholated Camel Kings were
shipped from Battelle on the day that custom-
mentholation was completed via overnight carrier with-
out refrigeration and all cigarettes were subsequently
stored at room temperature until processing. We included
two pairs of mentholated and non-mentholated products
(custom-mentholated Camel Kings versus non-
mentholated Camel Kings; and “non-crushed” Camel
Crush cigarettes versus “crushed” Camel Crush cigarettes,
as described above) so that we could specifically evaluate
the influence of the addition of menthol into two different
products on the bacterial community composition of
those products. Three lots of each cigarette product were
tested in replicates of 6 for a total of 90 samples (18 ciga-
rettes per brand) tested during the study.
DNA extraction
DNA extraction was performed on cigarettes from
freshly opened packages, with the exception of the
custom-mentholated and non-mentholated Camel Kings
(CK and CKM), which were opened at Battelle, proc-
essed and shipped as described above. Our total DNA
extraction protocol was adapted from procedures previ-
ously published [31, 32]. Briefly, each cigarette was dis-
sected under sterile conditions, and 0.2 g of tobacco was
weighed out and aseptically placed in Lysing Matrix B
tubes (MP Biomedicals, Solon, OH). Enzymatic lysis was
initiated by adding the following to the tubes containing
cigarette tobacco and lysing matrix: 1 ml of ice cold 1 ×
molecular grade PBS buffer (Gibco by Life Technologies,
NY), 5 μl lysozyme from chicken egg white (10 mg/ml,
Sigma-Aldrich, MO), 5 μl lysostaphin from Staphylococ-
cus staphylolyticus (5 mg/ml, Sigma-Aldrich, MO) and
15 μl of mutanolysin from Streptomyces globisporus
ATCC 21553 (1 mg/ml, Sigma-Aldrich, MO). Tubes
were then incubated at 37 °C for 30 min, after which a
second enzymatic cocktail was added to each tube, com-
posed of 10 μl Proteinase K (20 mg/ml, Invitrogen by
Life Technologies, NY) and 50 μl of SDS (10% w/v,
BioRad). Following incubation at 55 °C for 45 min, the
samples were then further lysed mechanically using a
FastPrep Instrument FP-24 (MP Biomedicals, CA) at
6.0 m/s for 40s. The resulting lysate was centrifuged for
3 min at 10,000 rcf and DNA was purified using the
QIAmp DSP DNA mini kit 50, v2 (Qiagen, CA), accord-
ing to the manufacturer’s protocol. Six replicate DNA
extractions were completed on each sample and negative
extraction controls were included to ensure that no
Table 1 Descriptions of cigarette products tested
Cigarette product Menthol status Abbreviation
Camel King filters Non-menthol CK
Camel King filters Mentholated (custom)a CKM
Camel Crush Non-mentholb CC
Camel Crush Mentholated (user)c CCM
Newport Menthol Box Mentholated (manufacturer)d NMB
aMentholated at The Battelle Public Health Center for Tobacco Research
bCamel Crush capsule within the filter was not crushed
cCamel Crush capsule within the filter was crushed in the laboratory prior to
DNA extraction
dCommercially mentholated by the manufacturer
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exogenous DNA contaminated the samples during ex-
traction. DNA quality control/quality assurance was per-
formed using spectrophotometric measurements on a
NanoDrop™ (Thermo Scientific, City, State), as well as
gel electrophoresis.
16S rRNA gene PCR amplification and sequencing
The V3-V4 hypervariable region of the 16S rRNA gene
was PCR-amplified and sequenced on Illumina MiSeq
(Illumina, San Diego, CA) using a dual-indexing strategy
for multiplexed sequencing developed at the Institute for
Genome Sciences and described in detail previously [33].
Briefly, PCR reactions were set-up in 96-well microti-
ter plates using the 319 F (ACTCCTACGGGAGGCAG-
CAG) and 806R (GGACTACHVGGGTWTCTAAT)
universal primers, each of which also included a linker
sequence required for Illumina MiSeq 300 bp paired-
ends sequencing, and a 12-bp heterogeneity-spacer
index sequence aimed at minimizing biases associated
with low-diversity amplicons sequencing [33, 34]. This
sample multiplexing approach ensured that 500 samples
could be multiplexed in a single Illumina MiSeq run.
PCR amplifications were performed using Phusion High-
Fidelity DNA polymerase (Thermo Fisher, USA) and
2 ng of template DNA in a total reaction volume of
25 μl. Because of the presence of PCR inhibitors in the
DNA solution, an additional 0.375 μl of bovine serum
albumin (BSA) (20 mg/ml, Sigma) was added to the PCR
reactions. Reactions were run in a DNA Engine Tetrad 2
thermo cycler (Bio-Rad, USA) using the following cyc-
ling parameters: 30 s at 98 °C, followed by 30 cycles of
10 s at 98 °C, 15 s at 66 °C, and 15 s at 72 °C, with a
final step of 10 min at 72 °C. Negative controls without
DNA template were performed for each primer pair. The
presence of amplicons was confirmed using gel electro-
phoresis, after which the SequalPrep Normalization Plate
kit (Invitrogen Inc., CA, USA) was used for clean-up and
normalization (25 ng of 16S PCR amplicons from each
sample were included), before pooling and 16S rRNA se-
quencing using the Illumina MiSeq (Illumina, San Diego,
CA) according to the manufacturer’s protocol.
Sequence quality filtering and analysis of 16S rRNA gene
sequences
16S rRNA reads were initially screened for low quality
bases and short read lengths [33]. Paired-end read pairs
were then assembled using PANDAseq [35] and the
resulting consensus sequences were de-multiplexed (i.e.,
assigned to their original sample), trimmed of artificial
barcodes and primers, and assessed for chimeras using
UCHIME in de novo mode implemented in Quantitative
Insights Into Microbial Ecology (QIIME ; release v. 1.9)
[36]. Quality trimmed sequences were then clustered de
novo into Operational Taxonomic Units (OTUs) with
the SILVA 16S database [37] in QIIME [36], with a mini-
mum confidence threshold of 0.97 for the taxonomic as-
signments. All sequences taxonomically assigned to
chloroplasts were removed from further downstream
analysis. Data were normalized to account for uneven
sampling depth with metagenomeSeq’s cumulative sum
scaling [38], a novel normalization method that has been
shown to be less biased than the standard approach
(total sum normalization).
Taxonomic assignments of the most abundant genera,
contributing >1% of the total abundance in at least one
sample, were obtained through QIIME [36] and visualized
with RStudio Version 0.99.473 and vegan [39], gplots [40],
RColorBrewer [41] and heatplus [42] R packages. Prior to
normalization, alpha diversity was estimated with the
Chao1 estimator [43], and the Shannon Index [44]
through the R packages: Bioconductor [45], metagenome-
Seq [46], vegan [39] phyloseq [47] and fossil [48]. To ac-
count for uneven sampling depth, the data were also
rarefied to the minimum sampling depth of 631 se-
quences. Alpha diversity data was tested for significance
using a Tukey test. Beta diversity was determined through
principle coordinates analysis (PCoA) plots of Bray-Curtis
distance performed through QIIME and tested for signifi-
cance with ANOSIM (9,999 permutations) [49].
Determination of statistically significant differences (p <
0.05) in OTU bacterial relative abundance between men-
tholated cigarette products and their non-mentholated
counterpart (mentholated Camel Crush vs. non-
mentholated Camel Crush and custom-mentholated
Camel Kings vs. non-mentholated Camel Kings) was per-
formed using DESeq2 [50] through QIIME [36], which
utilizes Benjamini-Hochberg multiple-inference correc-
tion. DESeq was used due to its high power in computing
smaller sample sizes (<20 samples per group) [51]. The
significant OTUs (p < 0.05) were visualized with RStudio
Version 0.99.473 and R packages ggplot2 [52], vegan [39],
and phyloseq [47]. In addition, species-level assignments
were performed for OTUs of interest: reference sequences
matching assigned genera of each OTU were extracted
from the Ribosomal Database Project (RDP; http://
rdp.cme.msu.edu/), aligned with the sequences from the
OTU(s) of interest via MAFFT [53], and the V3-V4 region
extracted. An unrooted maximum likelihood tree with 10
bootstrap replicates was generated with PhyML [54] for
each of the alignments. Trees were visualized with FigTree
[55] and branches colored based on species.
Results
Sequencing data and taxonomic assignments
All 90 cigarette samples were successfully PCR amplified
and sequenced, thus validating our DNA extraction and
purification protocol. A total of 2046 different bacterial
OTUs (97% identity) were identified from a total of
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909,053 sequences across all samples, and the average
number of sequences per sample was 10,100 (+/− 5004
SD, Additional file 1: Figure S1).
The average relative abundance of the most dominant
genera (>1.0% in at least one sample) showed that, across
all brands, bacteria from the genus Pseudomonas domi-
nated, followed by unclassified members of the Enterobac-
teriaceae family, and members of the Pantoea and
Bacillus genera (Fig. 1). Members from the Pseudomonas
genus were comprised of 15 unique OTUs, with 7 Pseudo-
monas OTUs shared between all mentholation states
(OTU#s 1532, 10, 134, 1868, 1886, 8, and 3). Some of
these shared Pseudomonas OTUs were assigned via RDP
classification using SILVA to Pseudomonas oryzihabitans
(OTUs #1868 and 6) and Pseudomonas putida (OTU #3)
species. Certain OTUs were also unique to the different
menthol products, including OTU #1250 and OTU #1137
for NMB and OTU #77 for CCM. Species level taxonomic
information was assigned only to OTU #1137, Pseudo-
monas fulva species. In addition, heatmap hierarchical
clustering of the samples revealed that the bacterial com-
munity profiles were more similar between the non-
menthol cigarette products CK and CC, compared to the
commercially mentholated (NMB) and custom-
mentholated (CKM) products (Fig. 1).
Alpha and beta diversity metrics by product and menthol
state
Because sequence coverage can have an impact on
measuring alpha diversity, a quantification of intra-
Fig. 1 Heat map showing the relative abundances of the most dominant bacterial genera identified (>1%) in tested cigarette products. Samples
pooled by product type: Camel Crush (CC), mentholated Camel Crush (CCM), Camel Kings (CK), custom-mentholated Camel Kings (CKM), and
Newport Menthol Box (NMB). Hierarchical clustering of the pooled samples is represented by the dendrogram at the top and inside the color key
shows a histogram of the count of the individual values
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sample diversity, we employed Chao1 and Shannon indi-
ces (Fig. 2) on both non-rarefied (Fig. 2a) and rarefied
data (Fig. 2b). Tobacco-associated microbiota from the
custom-mentholated Camel King (CKM) exhibited
significantly lower Chao1 diversity (p value <0.05) com-
pared to its non-mentholated counterpart (CK), regard-
less of rarefaction (Fig. 2).
To quantify inter-sample diversity (beta diversity),
principal coordinate analyses using the Bray Curtis dis-
tance, a measure widely used to measure the compos-
itional dissimilarity between two different sites in
ecology and microbiome studies, were performed. Separ-
ation of the tobacco-associated bacterial profiles was evi-
dent along the first principal component (PC1), which
explained 8.59% of the total variability between commu-
nities, and the second principal component (PC2), which
explained 5.95% of the total variability between commu-
nities by brand (ANOSIM R = 0.35, p = 0.0001) and
mentholation status (ANOSIM R = 0.43, p = 0.0001)
(Fig. 3). This was especially evident for the
commercially-mentholated, custom-mentholated and
non-mentholated products. Unweighted and weighted
UniFrac distances [56] were also used to measure beta
diversity between the brands (Additional file 1: Figure
S2), (ANOSIM R value = 0.25, p = 0.0001) and (ANOSIM
R = 0.16, p = 0.0001), respectively.
Taxonomic analysis by product and menthol status
There were 173 OTUs at statistically significantly (p <
0.05) different relative abundances between custom-
mentholated Camel Kings and non-mentholated Camel
Kings (Additional file 1: Table S1, Fig. 4). Out of these,
167 OTUs were at lower relative abundance in the
custom-mentholated Camel Kings, of which 116 were
Gram-negative (Fig. 4a), with species level assignments
including Achromobacter sp. HJ-31-2 (OTU #16), Azos-
pirillum irakense (OTU #167), Acinetobacter calcoaceti-
cus (OTU #40), Pseudomonas putida (OTU #3),
Stenotrophomonas maltophilia (OTU #15), Pseudo-
monas aeruginosa (OTU #420), Erwinia chrysanthemi
(OTU #446), Proteus mirabilis (OTU #450), Acinetobac-
ter baumannii (OTU #29), Agrobacterium tumefaciens
Fig. 2 Box plots showing alpha diversity (Chao1 richness estimator and Shannon Index) variation across samples on non-rarefied data (a) and
with data rarefied to the minimum sampling depth (b). Bars are colored by mentholation status: red bars—non-mentholated; green bars—user
mentholated; blue bars—custom-mentholated; purple bars—commercially-mentholated
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(OTU #1998), and Pseudomonas oryzihabitans (OTU
#1868). The remaining 51 OTUs at lower relative
abundance in custom-mentholated Camel Kings were
Gram-positive (Fig. 4b), with species level assignments
including Paenibacillus amylolyticus (OTU #37), Paeni-
bacillus montaniterrae (OTU #91), Paenibacillus sp.
icri4 (OTU #51), Streptomyces sp. KP17 (OTU #52), Ba-
cillus pumilus (OTU #1937, 5, 1948), Bacillus cereus
(OTU #176), Bacillus novalis (OTU #530 and 1442), Ba-
cillus clausii (OTU #9), and Bacillus licheniformis (OTU
#41). In addition, six OTUs were at higher relative abun-
dance in the custom-mentholated Camel Kings and were
composed of two Gram-negative bacteria, Schlegelella
sp. (OTU #87) and Silanimonas sp. (OTU #207) (Fig. 4a),
and four Gram-positive bacteria, Anoxybacillus sp.
(OTU #31), Vagococcus sp. (OTU #54), Deinococcus sp.
(OTU #272), and Thermus sp. (OTU #266) (Fig. 4b).
There were 60 OTUs at statistically significantly (p <
0.05) different relative abundances between mentholated
Camel Crush and non-mentholated Camel Crush
(Additional file 1: Table S2, Fig. 5). Twenty-two OTUs
were at lower relative abundance in the mentholated
Camel Crush and, of these, 10 were Gram-negative
OTUs (Fig. 5a) including Aeromonas sp. (OTU #285),
Cedecea sp. (OTU #783), unknown Sphingomonadales
(OTU #333), Stenotrophomonas sp. (OTU #1682), Para-
coccus sp. (OTU #289), unknown Enterobacteriaceae
(OTU #1969, 2017), Sphingobacterium sp. (OTU #124),
and Pantoea sp. (OTU #398 and 1448). The remaining
12 OTUs at lower relative abundance in mentholated
Camel Crush were Gram-positive (Fig. 5b) and included
Bacillus sp. (OTU #30), Facklamia sp. (OTU #104),
Jeotgalicoccus sp. (OTU #73), Staphylococcus sp. (OTU
#143), Saccharopolyspora sp. (OTU #293), unknown
Streptomycetaceae (OTU #1729), Nocardioides sp. (OTU
#86), Paenibacillus sp. (OTU #128 and 340), unknown
Bacillaceae (OTU #296), unknown Bogoriellaceae (OTU
#193), and unknown Bacillales (OTU #667). Addition-
ally, 38 OTUs were at higher relative abundance in the
mentholated Camel Crush samples and consisted of 26
Gram-negative OTUs, with species assignments for
Azospirillum irakense (OTU #167) and Pectobacterium
carotovorum (OTU #48). The remaining 12 were
Gram-positive and included Sporosarcina sp. (OTU
#228), Lysinibacillus sp. (OTU #93), Solibacillus sp.
(OTU #90), Anoxybacillus sp. (OTU #31), Corynebac-
terium sp. (OTU #21 and 551), Aerococcus sp. (OTU
#14), unknown Bacillales (OTU #1182), Brevibacter-
ium sp. (OTU #153), Deinococcus sp. (OTU #272),
Lactobacillus plantarum (OTU #359), and Bifidobac-
terium sp. (OTU #535).
OTUs of interest were selected to confirm or predict
species-level assignments via phylogenic analyses (Add-
itional file 1: Figures S3 to S10). OTUs included Pseudo-
monas putida (OTU #3), Pseudomonas oryzihabitans
(OTU #8, 1868), Pseudomonas sp. (OTU #10, 77, 132,
134, 163, 251, 608, 972, 1250, 1532, 1872, 1886), Pseudo-
monas aeruginosa (OTU #420), Pseudomonas fulva
(OTU #1137), Actinobacter sp. (OTU #12, 182, 247, 870,
1900), Acinetobacter baumannii (OTU #29), Acinetobac-
ter calcoaceticus (OTU #40, 496), Proteus mirabilis
(OTU #450),
Anoxybacillus sp. (OTU #31), Vagococcus sp. (OTU
#54), Deinococcus sp. (OTU #272), Thermus sp.
Fig. 3 PCoA analysis plots of Bray-Curtis computed distances between cigarette products. a Points colored by brand: purple—Newport Menthol
(NMB); green—mentholated Camel King (CKM); blue—mentholated Camel Crush (CCM); orange—Camel Kings (CK); red—Camel Crush (CC)
(ANOSIM R value = 0.35, p value = 0.0001), (b) Points colored by mentholation status: green—non-mentholated; purple—user mentholated;
blue—commercially-mentholated; red—custom mentholated. (ANOSIM R = 0.43, p = 0.0001)
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(OTU #266), Stenotrophomonas sp. (OTU #1682,
1899, 1913), and Stenotrophomonas maltophilia
(OTU #15).
Distinct phylogenetic clustering could be seen among
the OTUs and representative species (Additional file 1:
Figures S3-S10). Pseudomonas oryzihabitans OTU #8
and 1868 and Pseudomonas aeruginosa OTU #420
claded with strains of their assigned species. Pseudo-
monas sp. OTU #10 and 1886 grouped closely with
strains of Pseudomonas putida, while OTUs #251, 1250,
and 134 claded with strains of Pseudomonas stutzeri
(Additional file 1: Figure S3). Although close to several
strains of Pseudomonas putida, OTU #3 did not group
within the large clades of this species (Additional file 1:
Figure S3).
Acinetobacter baumannii (OTU #29) and Acinetobac-
ter calcoaceticus (OTU #496) also clustered with strains
of their assigned species (Additional file 1: Figure S4).
Additionally, Actinobacter sp. OTU 12 grouped with
Acinetobacter baumannii (Additional file 1: Figure S4).
Stenotrophomonas sp. OTUs #1913 and 1682 appeared
close to one another within a clade of Stenotrophomonas
maltophilia. Stenotrophomonas maltophilia OTU #15
claded further away from OTUs #1913 and 1682, but
was also with strains of Stenotrophomonas maltophilia
(Additional file 1: Figure S5). Stenotrophomonas sp.
OTU #1899 appeared most phylogenetically related to
strains of Stenotrophomonas chelatiphaga (Additional
file 1: Figure S5). Anoxybacillus sp. (OTU #31) claded
closely to strains of Anoxybacillus flavithermus,
Fig. 4 Overview of relative abundances of bacterial OTUs that were statistically significantly different (p < 0.05) between custom-mentholated
Camel Kings (CKM) and non-mentholated Camel Kings (CK). OTUs are colored by Phylum and differentiated by Gram negative (a) and Gram
positive (b) classification. A positive log2-fold change value denotes an OTU that is significantly higher in custom-mentholated Camel Kings, while
a negative log2-fold change indicates an OTU that is significantly higher in non-mentholated Camel Kings. The dotted line and arrows highlight
the conversion in log2-fold change from negative to positive values
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Deinococcus sp. (OTU #272) appeared closely related to
strains of Deinococcus geothermalis, and Thermus sp.
(OTU #266) claded closely to Thermus scotoductus
(Additional file 1: Figure S6-8).
Discussion
It has been well established that smokers and those
exposed to secondhand smoke are more susceptible to
bacterial infections than are non-smokers [57]. There-
fore, characterizing this exposure and, more specifically,
the bacterial components of cigarette tobacco and their
additives, is an important step in uncovering the rela-
tionship between tobacco products and user-health. This
study aimed to provide comprehensive data concerning
bacterial communities present in mentholated and non-
mentholated cigarettes by utilizing next-generation se-
quencing technologies that, to date, have been underuti-
lized in the field of tobacco regulatory science.
The most abundant genus detected in all cigarette
products tested, regardless of mentholation status, was
Pseudomonas (Fig. 1). This was not unexpected as spe-
cies of Pseudomonas are ubiquitous in aquatic and ter-
restrial environments and have been hypothesized to be
a part of the core pulmonary bacterial microbiome [58].
Pseudomonas spp. have also been implicated as the
dominant genus in cases of chronic obstructive pulmon-
ary disease (COPD) [58], cystic fibrosis [59], and subjects
with decreased lung function [58], making their high
prevalence and high abundance within cigarette tobacco
a potential human health concern. Pseudomonas putida
Fig. 5 Overview of relative abundances of OTUs that were statistically significantly different (p < 0.05) between mentholated Camel Crush (CCM)
and non-mentholated Camel Crush (CC). OTUs are colored by Phylum and differentiated by Gram negative (a) and Gram positive (b) classification.
A positive log2-fold change value denotes an OTU that is significantly higher in mentholated Camel Crush, while a negative log2-fold change
indicates an OTU that is significantly higher in non-mentholated Camel Crush. The dotted line and arrows highlight the conversion in log2-fold
change from negative to positive values
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due to its metabolical versatility has a distinct associ-
ation with tobacco and human disease [60]. For in-
stance, several strains of Pseudomonas putida (e.g.
S16, J5, SKD, and ZB-16A) have the ability to degrade
nicotine [61–65], while others have emerged as sig-
nificant human pathogens causing urinary tract infec-
tions [66, 67] and nosocomial pneumonia [66, 68],
particularly in ill or immunocompromised patients. In
addition, it has been suggested that the clinical isolate
strain, HB3267, acquired antibiotic and biocide resist-
ance genes from opportunistic human pathogens, in-
cluding Acinetobacter baumannii [69], which was one
of the species found at higher relative abundance in
Camel Kings compared to its mentholated counter-
part (Fig. 4). Acinetobacter baumannii is a Gram-
negative opportunistic pathogen of particular global
concern due to its increasing rates of antibiotic resist-
ance [70–72] and connection to nosocomial pneumo-
nia and ventilator-associated pneumonia in patients
with underlying lung disease [70, 73, 74].
Additional common and rare bacterial species—some of
which are known to cause respiratory illnesses—were
found at higher relative abundances in the non-
mentholated Camel Kings compared to the custom-
mentholated Camel Kings, including Pseudomonas
oryzihabitans and Pseudomonas aeruginosa. Pseudomonas
aeruginosa is noteworthy as a member of the tobacco
microenvironment not only due to its association with the
occurrence and exacerbation of COPD but also due to its
response to cigarette smoke [75–77]. A study preformed
on murine models showed that exposure to cigarette
smoke followed by infection with Pseudomonas aeruginosa
resulted in delayed clearance of infection and increased
morbidity compared to controls [77].
Despite the overall decrease in bacterial diversity and
potential human pathogens that we observed in custom-
mentholated compared to non-mentholated Camel
Kings, we detected statistically significant (p < 0.05) in-
creases in the relative abundance of four Gram-positive
bacterial species (Thermus sp., Deinococcus sp., Vagococ-
cus sp., and Anoxybacillus sp.) and two Gram-negative
species (Silanimonas sp. and Schlegelella sp.) in the
mentholated product. Interestingly, Anoxybacillus and
Deinococcus include species that are able to withstand
extreme environmental conditions (e.g., elevated pH, in-
dustrial processes, UV treatment, radiation) [78–81],
possibly due to the production of protective carotenoids
found in strains of both genera [82–84]. Furthermore,
species of Thermus [85], Silanimonas [86] and Schlege-
lella [75] are known to be thermophilic, hyperthermo-
philic and/or alkaliphilic. For example, strains of
Thermus scotoductus have been isolated from a hot
water pipeline [87], a South African gold mine [88], and
a sulfide-rich neutral hot spring [89].
These data suggest that menthol may be effective
against Gram-negative bacteria in cigarette products and
select and/or introduce resilient bacterial species that
can tolerate the antibacterial activity of menthol.
Menthol, although known to be active against both
Gram-positive and Gram-negative bacteria [20], has
shown, in some instances, to be more effective against
Gram-negative bacteria, especially compared to other es-
sential oils [90]. Nevertheless, this overall trend was not
observed in our comparisons between the user-
mentholated Camel Crush and the non-mentholated
Camel Crush (Fig. 5). This finding may be due to the
degree and rate of menthol exposure in the user-
mentholated Camel Crush products. Because these ciga-
rettes are user-mentholated (by crushing a capsule
within the cigarette filter and releasing a menthol-
containing solution immediately before use), the tobacco
is generally exposed to the antibacterial effects of men-
thol only for a brief period of time before consumption,
if at all. For these products, we only evaluated a single
time point, just following menthol release; as a result the
menthol may not have had the opportunity to migrate
fully to the tobacco.
Our study had other limitations as well. We detected
more than 2000 OTUs, but as with all DNA-based 16S
rRNA gene-sequencing studies, future studies are re-
quired to confirm whether these bacteria are active and
capable of potentially colonizing a user exposed to these
microorganisms. It is also important to note that, chem-
ically, the only difference between the tobacco content
of the custom-mentholated Camel King and non-
mentholated Camel King cigarettes was the addition of
L-menthol. However, the mentholation process used to
produce the custom-mentholated Camel King could not
be performed under DNA-free conditions, and the intro-
duction of low levels of contaminating foreign bacterial
DNA, although unlikely, could be a possibility. Further-
more, commercially available cigarettes may differ from
each other in more ways than menthol content, such as
tobacco blend [8]. However, the presence of increasing
Anoxybacillus and Deinococcus OTUs in both custom
and user-mentholated products suggests a relationship
with menthol that should be further tested. Finally, we
evaluated the bacterial communities of cigarette prod-
ucts stored under one environmental condition.
Characterization of products stored under varying
temperature and relative humidity conditions would en-
able us to better predict the impact of typical daily stor-
age conditions (e.g., pocket conditions) on the dynamics
of the bacterial communities in mentholated and non-
mentholated cigarettes. Such experiments are currently
ongoing in our laboratory. Even with these caveats, our
study provides new knowledge regarding the bacterial
constituents of commercially mentholated and non-
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mentholated tobacco products and the potential import-
ance of these bacterial communities to human health.
From pre-harvest to puff, cigarette-associated bacteria
are a culmination of ecosystems and commercial manip-
ulations that result in a complex and diverse bacterial
community, which may contribute to the acquisition
and exchange of pathogenic and antibiotic resistance
genes and/or species selection. Our data suggest that to-
bacco flavor additives, such as menthol, can affect the
bacterial community composition of tobacco products
and may lead to the selection or introduction of more
resilient species. The bacteria and bacterial components
present in non-mentholated and mentholated cigarettes
may be introduced into the lung and oral cavity during
the smoking process, carried by the filter-end of the
cigarette butt and/or the tobacco particulate matter
within mainstream smoke [21, 24, 26, 28]. These bacter-
ial communities could play a direct role in the develop-
ment of infectious and/or chronic illnesses among users
or exacerbate existing negative health effects associated
with smoking.
Conclusions
This study comprehensively characterizes the complex
bacterial communities residing in mentholated and non-
mentholated cigarette products, which include bacterial
pathogens of importance to public health. Most import-
antly, our study also shows that mentholation of
cigarette products, a process used to reduce the harsh-
ness of cigarette products and appeal to a wider
spectrum of consumers, significantly impacts the bacter-
ial community of these products. Mentholation appeared
to be correlated with a reduction in potential human
bacterial pathogens and an increase in bacterial species
resistant to harsh environmental conditions. These find-
ings have critical implications regarding exposure to po-
tentially infectious pathogens among cigarette smokers,
and can be used to inform future tobacco control pol-
icies focused on the microbiology of tobacco, an under-
studied focus area in tobacco regulatory science.
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